StockData
Neogen Corp logo

Neogen Corp (NEOG) stock

NEOGNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 7, 2026Score 7/3049% above fair value
$11.08+0.18 (+1.65%)

Close on Nov 18, 2026Market cap $2.42BP/E –Yield –

Neogen market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Neogen's market cap was $2.53B on Nov 11, 2026, against $1.30B a year earlier. Over the last 5 years it ranged from $1.01B to $5.01B, with a median of $2.67B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$2.53B+66.7%
2025Dec 31, 2025$1.52B-42.3%
2024Dec 31, 2024$2.63B-39.5%
2023Dec 29, 2023$4.35B+164.9%
2022Dec 30, 2022$1.64B-66.4%
2021Dec 31, 2021$4.88B+16.1%
2020Dec 31, 2020$4.21B+22.9%
2019Dec 31, 2019$3.42B+15.4%
2018Dec 31, 2018$2.96B-5.7%
2017Dec 29, 2017$3.14B-5.3%
2016Dec 30, 2016$3.32B+17.8%
2015Dec 31, 2015$2.82B+15.4%
2014Dec 31, 2014$2.44B+10.2%
2013Dec 31, 2013$2.22B+54.1%
2012Dec 31, 2012$1.44B+50.6%
2011Dec 30, 2011$954.91M-24.4%
2010Dec 31, 2010$1.26B–

More Neogen figures

See a number that looks wrong?